# Antigen-specific Cytotoxic T Cells in the Treatment of Opportunistic Infections

> **NCT03159364** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Shenzhen Geno-Immune Medical Institute** · enrollment: 100 (estimated)

## Conditions studied

- Pathogen Infection
- EBV Infection
- CMV Infection
- Adenovirus Infection
- BKV Infection
- Fungus Infection
- Tuberculosis

## Interventions

- **BIOLOGICAL:** pathogen-specific CTLs

## Key facts

- **NCT ID:** NCT03159364
- **Lead sponsor:** Shenzhen Geno-Immune Medical Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-07-15
- **Primary completion:** 2020-07-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2019-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03159364

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03159364, "Antigen-specific Cytotoxic T Cells in the Treatment of Opportunistic Infections". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03159364. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*